SUMMARY The spectrum of organ involvement in 50 patients with systemic lupus erythematosus has been assessed in a prospective study. All patients were admitted to hospital electively for 2 days and a complete clinical and laboratory assessment protocol completed. Subsequent hospital admissions depended on clinical status. The overall mean observation period was 29 months. Widespread multisystem involvement was found in every patient. Subclinical abnormalities of respiratory and cerebral function were common even in patients in clinical remission. A more conservative approach than has been generally recomnmended was used for the management of systemic lupus erythematosus and is supported by the estimated 5-year survival of 98 %.
During recent years considerable change in emphasis has occurred in the clinical description of systemic lupus erythematosus (SLE). From being a rare disease, usually ending in death from nephritis, it is now regarded as a relatively common illness in which mild forms with a good prognosis are being increasingly recognised. These apparent changes in the nature of SLE have been at least partially due to a growing awareness of the disease and the addition of sensitive serological tests to the clinical and pathological diagnostic methods. Several large series have described the clinical features of SLE (Estes and Christian, 1971; Dubois et al., 1974; Fries and Holman, 1975; Lee et al., 1977) . The present report, a prospective analysis beginning in 1973, is the first in which the clinical diagnosis has been supported by the finding of raised levels of anti-DNA antibodies in each patient. The aim of the study was to analyse prospectively the pattern of organ involvement in SLE using all currently available techniques. All patients were admitted to hospital on at least one occasion for a complete clinical assessment, regardless of apparent disease activity. We report the findings in the first 50 patients studied.
Methods PATIENT 
SELECTION
Since January 1971, 121 patients with the clinical Accepted for publication July 21, 1977 Correspondence to Dr G. R. V. Hughes diagnosis of SLE confirmed by the presence of anti-DNA antibody have been seen at Hammersmith Hospital on one or more occasions. The patients were referred from local practitioners, from other centres in the United Kingdom, and from centres abroad. About half were referred directly to the rheumatology unit. Others were seen initially in other departments, particularly nephrology and haematology. A sample of 50 successive patients who were referred to the rheumatology unit after July 1973, and who have since been followed up regularly were entered into a prospective study.
A systematic collection of predefined clinical and laboratory data was made over the period ofobservation. The frequency of outpatient attendances was determined according to the clinical status. At each visit a detailed clinical examination was recorded and blood taken for erythrocyte sedimentation rate, full blood count including differential white cell count, anti-DNA antibodies, and complement (C3). A further aliquot was stored at -20QC. Each patient has at some point undergone a planned 48-hour hospital admission for the purpose of carrying out a comprehensive investigative profile according to a predetermined protocol (see Table 1 ). The patients were not necessarily symptomatic at the time of this admission. Patients who were already being followed at the rheumatology unit before the start of the study in July 1973 have also been included. Otherwise, no retrospective analysis of this study group has been performed.
In order to evaluate possible selection bias of the study sample, the major clinical features of the total (Holborow et al., 1957) . Anti-DNA antibodies were detected by the Farr ammonium sulphate precipitation test using 14C DNA (Pincus et al., 1969; Lewkonia et al., 1977) . Antibody to extractable nuclear antigen and its major components was detected by counterimmunoelectrophoresis (Kurata and Tan, 1976) . Lymphocytotoxic antibodies were measured using the two-stage microcytotoxicity assay (Terasaki and McClelland, 1964) . Serum complement components, C3, C4, and Clq were measured by radial immunodiffusion. Total haemolytic complement (CH50) was also measured.
Pulmonary investigations
The techniques used have been described elsewhere (Gibson et al., 1977 Table 3 and are compared with previous series (Estes and Christian, 1971; Dubois et al., 1974; Lee et al., 1977) . Musculoskeletal and skin involvement were the most frequent manifestations and occurred at some time in 49 of the patients. The percentage distribution of most individual manifestations in the 50 study patients was in general agreement with the other series. Only in the case of alopecia was there a statistically significant discrepancy.
Forty-six (92%) of the 50 patients developed 4 or more positive ARA preliminary criteria for the classification of SLE (Cohen et al., 1971) . The mean number of positive criteria in each patient was 6.0. The 4 patients who did not fulfil the ARA criteria had persistently raised DNA binding values.
SKIN AND MUCUS MEMBRANES (TABLE 4)
Skin and mucus membrane manifestations were recorded in 49 of the 50 patients. Varieties of cutaneous vasculitis seen included digital vasculitis, nail fold lesions, periungual erythema, palmar and plantar rashes, and erythematous and maculopapular lesions, particularly on the elbows and breasts. Although no significant correlation could (Sharp et al., 1972; Bresnihan et al., 1977a) .
Purpura was associated with thrombocytopenia in 7 of the 9 patients in whom it occurred. 11 patients developed subcutaneous nodules similar to those seen in rheumatoid arthritis. These were all less than 0 5 cm in diameter, and were found on the elbow and extensor surfaces of the forearm, the fingers, and in one patient the scalp. Discoid lesions, mainly affecting the upper portion of the body, were seen in 10 patients, and were the presenting manifestation in 3.
MUSCULOSKELETAL MANIFESTATIONS (TABLE 5) Polyarthritis or arthralgia was recorded in 49 of the 50 patients and was the presenting feature in 31 patients. Jaccoud's deformity (Bywaters, 1975) was seen in 3 patients and small radiological erosions in a further 3 patients. Avascular necrosis of bone was detected in 3 patients. One' patient, with severe bilateral femoral head involvement, underwent bilateral total hip replacement. One male patient had bilateral knee joint involvement with only mild symptoms. One female had avascular necrosis of a carpal lunate. All 3 patients had been on long-term maintenance doses of prednisone, one patient having received 5 mg/day for 6 years, one 10 mg/day for 12 years, and the third 10 mg/day for 15 years.
Sixteen patients described recurrent episodes of muscular pain, particularly affecting the proximal muscles, and sometimes associated with tenderness. Serum muscle enzyme levels were measured frequently, but raised levels were found in only 2 patients. Varying degrees of proximal weakness in some patients were attributed to corticosteroid myopathy. 6 patients developed gradual contractures of the flexor muscles and tendons of the forearms leading to 'clawing' of the fingers. This led to considerable pain and disability in one, despite regular splinting and physiotherapy.
PULMONARY MANIFESTATIONS (TABLE 6) Pulmonary manifestations attributable to SLE were found in 41 patients. 32 patients had had symptoms at some stage. 26 had a history of pleuritic pain which was often recurrent. 20 complained of undue breathlessness on exertion.
The most common radiological abnormality was a raised diaphragm above the level of the anterior ends of the fifth ribs (9 patients). This was associated with basal linear shadows in 2 patients, but in 6 it was the only abnormality. 5 of the 26 patients with pleurisy showed pleural shadows on x-ray. Diffuse pulmonary infiltrates characteristic of lupus pneumonitis which were unresponsive to antibiotics but cleared with systemic corticosteroids were seen in 2 patients. Only 2 of the 29 perfusion scans were abnormal, and these abnormalities corresponded with lesions seen on x-ray.
Pulmonary function tests were performed on 42 patients, 13 of whom had never had respiratory symptoms. The results from 30 patients have been previously described (Gibson et al., 1977) . Functional abnormalities, defined as values below 80 % of predicted, were found in 37 of the patients (88%) including 8 of the 13 asymptomatic patients. Reduction of the carbon monoxide transfer factor (TLCO) was found in all 37 patients. The diffusion constant, KCO (calculated by dividing the TLCO by the alveolar volume) was reduced in 23 of these patients, but was normal in the remaining 14. Reduced lung volumes (present in 41 %) appeared to account for most of the total lung diffusion abnormalities in this latter group, as the total lung capacity (TLC) was reduced in 13 of the 14 patients with normal KCO. Only 4 patients had abnormalities of both TLC and KCO. Overall, there was a highly significant negative correlation between KCO and TLC. All 5 patients with normal respiratory function tests were asymptomatic and had normal x-rays. In 7 of the patients with the smallest lung volumes, measurements of static pressure volume curves and of mouth pressures during maximum efforts indicated extrapulmonary volume restriction. In 5 of these patients diaphragm function was specifically assessed and found to be grossly abnormal in 4. No correlation was found between pleurisy or lung function abnormalities and any other manifestation of SLE.
RENAL MANIFESTATIONS (TABLE 7) Renal involvement was defined as at least one of the following: cellular casts in the urine, haematuria (5 or more red blood cells per high power field), serum creatinine >150 ,umol/l, proteinuria of at least 1 g/24 h, or histological changes compatible with SLE on renal biopsy. The indications for renal biopsy generally were persistent urinary or renal function abnormalities, usually in association with hypocomplementaemia. Each biopsy was examined by light and electron microscopy and by immunofluorescence.
By these criteria, lupus nephritis was diagnosed in 20 (40%) of the 50 patients. 15 Membranous glomerulonephritis with widespread basement membrane thickening, but without cellular proliferation was seen in one patient.
Fourteen of the 20 patients with lupus nephritis, including 13 of the 17 with abnormal histology, had a low serum complement (C3) recorded on more than one occasion during the period of observation. 14 of the 30 other patients who did not have lupus nephritis as defined above also had a low C3. There was no statistically significant difference in the cumulative incidence of hypocomplementaemia in the patients who developed clinically manifest nephritis at some stage during their period ofobservation and those who did not. It is very possible that the incidence of renal involvement in this series as in other series, has been underestimated. Abnormal histology was found in 3 patients with normal urinalysis and renal function but who had hypocomplementaemia. This has been found previously (Baldwin and Gallo, 1975; Lee et al., 1977) .
NEUROPSYCHIATRIC MANIFESTATIONS (TABLE 8) Neuropsychiatric manifestations were observed in 25 patients (50%). Organic brain syndromes, characterised by impairment of orientation, perception, memory, or intellectual function of judgment (Klippel and Zvaifler, 1975) , were seen in 9 patients. Additional neurological manifestations were associated in 8 of these patients. Onset was often sudden and dramatic and precipitated by stress as occurred in one patient during school examinations and another on the morning of her wedding. Corticosteroid side effects were not thought to be responsible for any of the episodes we observed. Several patients improved rapidly after an increased dose of prednisone.
Nonorganic syndromes, particularly depression, of severity such that the attending physician modified the patient's treatment for this reason, were seen in 11 patients. Lesser degrees of depression and anxiety and other symptoms which could not with A previous report from this unit pointed out that no single test or group of tests will establish a definite diagnosis of cerebral lupus (Bennett et al., 1972) . The electroencephalogram (EEG) was the most frequently abnormal investigation performed in this study. Of the 39 patients studied during the 48-hour hospital admission, abnormal EEGs were recorded in 10 of the 11 patients who had neuropsychiatric manifestations at that time, 7 of the 11 patients who had had neuropsychiatric manifestations 4 months to 12 years before but were asymptomatic at the time of testing, and 7 of the 17 patients who had no past or current clinical evidence of neuropsychiatric involvement. The best correlation was found in the 9 patients with organic brain syndromes, all of whom had abnormal EEGs. The most frequent pattern of abnormality was diffuse slow wave activity, but some had definite focal features or a combination of the two. Brain scan abnormalities were unusual, being found in only 3 of 37 patients tested. Fluorescein angiography showed capillary leakage in 11 of 24 patients studied, 3 of whom had no other evidence of cerebral lupus (Edmonds et al., 1975) .
No correlation could be found between neuropsychiatric involvement and other manifestations. The group of 25 patients with clinical neuropsychiatric manifestations also included 23 of the 41 with lymphopenia, 20 of the 35 with cutaneous vasculitis, and 9 of the 13 with thrombocytopenia, but none of these associations was statistically significant. Lupus nephritis was equally prevalent in those patients with and without neuropsychiatric involvement.
HAEMATOLOGICAL MANIFESTATIONS (TABLE 9) The lower limit of normal for haemoglobin was arbitrarily defined as 11 g/dl, leucocyte count 4-0 x 109/1, lymphocytes 1 .2 x 109/1, and platelets 120 x 109/l. An abnormality was recorded if two or more measurements made on separate occasions, in the absence of drugs likely to depress bone marrow function, were below normal.
Anaemia was most commonly normochromic, normocytic. 8 patients had positive Coombs's test. Leucopenia was noted in 23 (46%) patients, but an absolute lymphopenia was found to be much more common (41 patients). Mild thrombocytopenia occurred in 13 (26 %).
SEROLOGICAL MANIFESTATIONS (TABLE 10) Serum from all patients contained antinuclear antibodies. Anti-DNA antibodies were also present in all patients at some stage during the observation period. Anti-ENA (extractable nuclear antigens) antibodies were found in 20 % of patients. There was no correlation between anti-ENA antibodies, antiribonucleoprotein antibody, or anti-Sm antibody and individual clinical features (Bresnihan et al., 1977b) . Lymphocytotoxic antibodies were present in 80% of patients and correlated quantitatively with the presence of neuropsychiatric (P<0-001) and cutaneous (P <0-004) manifestations (Bresnihan et al., 1978) . The LE cell test was performed infrequently during the latter part of the study, but was positive in 29 of 34 patients tested (85 %). Raised gammaglobulins in excess of 1.5 g/100 ml was observed in 63 %. IgG was raised in 22 % of patients, IgA in 13 %, and IgM in 9%. 4 patients had mild reduction of one or more immunoglobulin fractions, but very low levels were not recorded.
OBSTETRIC AND GYNAECOLOGICAL MANIFESTATIONS
A more detailed study of SLE and pregnancy in a larger group of patients has been reported elsewhere (Grigor et al., 1977) . 37 female patients were aged between 15 and 45 years at the time of the study. Secondary amenorrhoea of more than 3 months' duration occurred in 10 (27%). 9 patients were taking a mixed hormone contraceptive tablet without obvious deleterious effects on the course of their SLE. In one patient onset of the disease coincided with the start of oral contraceptive therapy.
Twenty-five pregnancies have occurred in 14 patients since the onset of clinical manifestations of SLE. Of these, 7 (25%) ended in spontaneous abortion or stillbirth, while the remainder resulted in normal deliveries. Exacerbations of disease activity, sufficient to require increased corticosteroid dose, occurred in association with 10 pregnancies, most commonly during the puerperium. In 3 patients the first clinical manifestations of SLE occurred during pregnancy. 50 pregnancies occurred in 18 patients before the onset of clinical manifestations of SLE, of which 15 (30%) ended in fetal death. PATIENT 
SELECTION
In Table 11 the major clinical manifestation of the 50 study patients are summarised and compared with the overall incidence. The incidence of pulmonary, cardiac, neuropsychiatric, and haematological manifestations were similar but minor differences in the incidence of skin and joint manifestations and of nephritis were seen, possibly The most frequently prescribed nonsteroidal drug were aspirin, indomethacin, and proprionic acid derivatives. These drugs usually controlled fever, arthritis, and serositis. In 3 patients transient disturbance of liver enzymes were seen during aspirin administration. Chloroquine was used for periods of up to 1 year in 6 patients. 16 patients with nephritis received azathioprine or cyclophosphamide. We did not attempt to evaluate the effect of different immunosuppressive drug regimens.
PROGNOS1S
The 50 patients were followed for a total of 1433 patient months, average 28 7 months, range 1 week (patient died) to 72 months. 3 patients (6 %) died, of chronic renal failure, cerebral infarction, and septicaemia. Another 3 patients were lost to followup.
Survival was calculated using the time of entry to the study as the starting point (Merrell and Shulman, 1955) . On this basis the overall estimated survival for the patients in the study at 5 years was 98 % and at 10 years 76.7 %. The average duration of disease from the time of initial manifestation until entry into the study was 7.7 years. Using the first symptom as starting point, the estimated 5-year survival was 98%, and 10 year survival 89 4%. The time of diagnosis was/iot used as a starting point as it had usually been made in another centre and exact ;ming was difficult to determine. The indications for using various starting points for calculation of survival rates has been discussed by Fries et al. (1974) and Lee et al. (1977) .
The survival figures reflect the steadily improving life expectancy that has been described in SLE since 1954. Merrill and Shulman (1955) reported 51 % estimated survival for 4 years. Kellum and Haserick (1964) reported a 5-year survival of 69 %, Estes and Christian (1971) 77%, and Lee et al. (1977) 
